Skip to content
  • University Home
  • Academics
  • Admissions
  • Campus Life
  • Research
  • About
  • Apply
  • Giving
Clemson News

Clemson News

  • Topics
    • OUR Clemson
    • Impact and Innovation
    • Student Success
      • Spring of 2024 President’s List
      • Spring of 2024 Dean’s List
    • Faculty and Staff Achievements
    • Alumni Accomplishments
    • Infectious Disease Research
    • Commentary And Analysis
    • All Stories
    • Clemson In The News
    • Celebrating Our Graduates
    • Military Traditions
  • Colleges
    • College of Agriculture, Forestry and Life Sciences
    • College of Architecture, Art and Construction
    • College of Arts and Humanities
    • College of Behavioral, Social and Health Sciences
    • College of Education
    • College of Engineering, Computing and Applied Sciences
    • College of Science
    • Harvey S. Peeler Jr. College of Veterinary Medicine
    • Wilbur O. and Ann Powers College of Business
  • Divisions
    • Office of the President
    • Office of the Provost
    • Advancement
    • Marketing and Communications
    • Clemson Computing Information Technology
    • Community, Engagement, Belonging and Access
    • External Affairs
    • Finance and Operations
    • Clemson Libraries
    • Institutional Excellence
    • Public Service and Agriculture
    • Research
    • Student Affairs
    • Athletics
  • For Journalists
    • Our Experts
Clemson.edu Resources
  • University Home
  • Academics
  • Admissions
  • Campus Life
  • Research
  • About
College of Behavioral, Social and Health Sciences

Psychology, Public Health Sciences faculty and Prisma Health lead national study demonstrating hepatitis C cure in people who inject drugs

Frances Parrish

Share:

Download image
August 3, 2023March 13, 2024

Hepatitis C is rampant among people who inject drugs, and a team of Clemson University and Prisma Health researchers led a nationwide study, funded by the Patient-Centered Outcomes Research Institute, that proved the success of two models of treatment to cure the disease. 

Hepatitis C is a liver infection and is spread through contact with blood from an infected person. Most people become infected with the virus by sharing needles or other drug-use equipment. While there is no vaccine for hepatitis C, it can be cured through medicine. Since 2013, the number of new cases of hepatitis C infections has increased each year in the U.S. In 2020, the latest reported year from the Centers for Disease Control and Prevention, 4,798 new short-term infections and 107,300 new chronic cases were reported.

The two models of care in the study – patient navigation and modified directly observed therapy – are most commonly used at outpatient treatment centers and community treatment centers; however, the effectiveness of these models had not yet been directly observed in people injecting drugs, until now.

Patients in eight opioid treatment programs and 15 community health centers in New York City, New York; Providence, Rhode Island; Albuquerque, New Mexico; San Francisco, California; Boston, Massachusetts; Baltimore, Maryland; Seattle, Washington; and Morgantown, West Virginia participated in the study.

Patient navigation is a community-based service delivery intervention designed to promote access to timely diagnosis and treatment of cancer and other chronic diseases by eliminating barriers to care. Modified directly observed therapy (mDOT), in which medicine is taken under supervision, assists patients in maintaining adherence to complicated antiretroviral therapy.

The primary outcome of the study was to assess the cure rate, and the secondary outcomes were to assess treatment initiation, adherence, completion and reinfection rates. The team thought patient navigation would be associated with greater treatment initiation and completion and mDOT would be associated with a higher cure rate. However, they found that both outcomes are relatively the same, as treatment completion was more than 80% in both treatment groups.

Participants of the study received a tablet of sofosbuvir (400 mg) with velpatasvir (100 mg) once daily for 12 weeks, while receiving one of the two models of care. The patient was considered cured if they no longer had detectable amounts of the virus for 12 weeks or more after they completed their therapy. The study included 755 participants – 379 were randomized to patient navigation and 376 to modified directly observed therapy. Overall, 623 (82.5%) initiated treatment and 462 (74.2%) were cured. In the sample where all participants obtained follow-up viral load testing, 461 out of 501 participants (92.0%) achieved cure.

The team did find there is a need for continued follow-up to monitor for reinfection and to reinitiate curative treatment, if necessary, but they found that both models are successful in curing the disease either in community-based or methadone maintenance treatment settings.

“Results from the study demonstrate that we can successfully treat hepatitis C in people who are injecting drugs with either patient navigation or modified directly observed therapy,” said Alain Litwin, MD, principal investigator and faculty member in the College of Behavioral, Social and Health Sciences. “This is a curable disease, and we need to urgently scale up these co-located models of hepatitis C care across the United States in order to achieve elimination of this disease.”

Litwin, professor of practice in the Department of Psychology and executive director of Prisma Health Addiction Medicine Center, as well as co-director of the Clemson University Center for Addiction and Mental Health Research, led this nationwide study with the help of Irene Pericot-Valverde, Ph.D., project director and assistant professor in the Department of Psychology, and Moonseong Heo, Ph.D., professor in the Department of Public Health Sciences and project lead biostatistician.

Each city had a team of researchers that consisted of faculty and team members from Johns Hopkins Bloomberg School of Public Health, University of Washington, Harvard Medical School, Montefiore Medical Center, West Virginia University, Brown University School of Medicine, University of Rhode Island, University of New Mexico and the University of California San Francisco.

This study was published in the Lancet Gastroenterology and Hepatology journal. The study, Patient-Centered Model of HCV Care for People who Inject Drugs, was conducted in collaboration with national and local stakeholders including patients, advocacy organizations, industry partners, health departments and taxpayers.

The research reported in this article was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (HPC-1503-28122-IC)

The statements in the article are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or the Methodology Committee.


The Department of Psychology and the Department of Public Health Sciences are part of the College of Behavioral, Social and Health Sciences, a 21st-century land-grant college joining together a unique combination of schools and departments: Communication, Nursing, Parks, Recreation and Tourism Management, Political Science, Psychology, Public Health Sciences and Sociology, Anthropology and Criminal Justice. These areas have distinctive characteristics and missions – all joined together by a common thread of service to people and communities.

Want to Discuss?

Get in touch and we will connect you with the author or another expert.

Or email us at news@clemson.edu

    This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
    School of Health Research (CUSHR)

    Clemson News

    Clemson News is the go-to source for stories and news about the innovations, research and accomplishments of the Clemson Family.

    • Contact Us

    Media Resources

    • For Journalists
    • Find an Expert

    Clemson Publications

    • Clemson World
    • Decipher
    • Orange. The Experience.
    • Clemson TV

    Policy/Terms of Use

    • Web Accessibility
    • Title IX
    • Non-Discrimination & Anti-Harassment Policy
    • Ethics/Safety Hotline
    • Privacy Policy

    Copyright © 2025. All Rights Reserved.

    Clemson University